跳至主要内容
临床试验/EUCTR2018-004096-12-NL
EUCTR2018-004096-12-NL进行中(未招募)1 期

Open-label randomized controlled trial for the effects of continuous ethinylestradiol/levonorgestrel (30/150 µg/day) compared with vitamin E (400 IU/day) in the treatment of menstrually-related migraine and migraine during perimenopause - WHAT! - RCT

MC0 个研究点目标入组 360 人开始时间: 2019年4月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
MC
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - women with menstrually-related migraine or pure menstrual migraine.
  • - women with migraine in the menopausal transition phase.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 360
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • smoking, migraine with aura, breastfeeding/pregnancy, contraindications for the use of microgynon30/vitamin E

研究者

发起方
MC

相似试验